This antiviral drug that blocks CAP snatching in Influenza A and B viruses. Without the cap, viral mRNAs cannot be translated. It is used for treatment of acute uncomplicated influenza within 2 days of illness onset in adults and adolescents who are otherwise healthy or at high risk of developing flu-related complications.

Question

Quizplus · Accepted Answer

Baloxavir blocks CAP snatching, a mechanism critical for viral mRNA translation, making it effective against Influenza A and B when administered early in the course of the illness.

This Antiviral Drug That Blocks CAP Snatching in Influenza a and B